Isotechnika Pharma Inc IPHAF

RE: RE: RE: RE: RE: follow up news is not good

[teevee]

Waskerwisk,
It appears to be  in Paladin's  best interests if ISA were to "go away" as, if ISA were to go under, I doubt any partnership agreements would survive the bankruptcy as Paladin retains the IP. Assuming there is some real value to ISA's licences from Paladin, and that Lux's NDA has a real chance of success, considering the ongoing delays may now jeopardize the survival of ISA, the lowest cost way for Lux to protect their investment would be to merge with ISA. Lux's backers obviously have deep pockets and on a share exchange basis, the dilution to Lux would be low.